Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Moskowitz

Showing results (131-140 of 280) with videos related to

Pageof 28
Sort By:
JAMA Dermatology|November 22, 2013
Disseminated mantle-cell lymphoma presenting as a petechial maculopapular eruptionSarah I Jawed, Travis J Hollmann, Craig H Moskowitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2003
Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphomaA D Zelenetz, P Hamlin, T Kewalramani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphomaKaryn A Goodman, Elyn Riedel, Victoria Serrano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2022
Prognostic Value of <sup>18</sup>F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy RegimenLaure Michaud, Kurt Bantilan, Audrey Mauguen, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1994
Synthesis of an antileishmanial alkaloid isolated from Galipea longiflora and of related compoundsM H Munos, J Mayrargue, A Fournet, et al.
Insect Biochemistry and Molecular Biology|June 14, 2000
Isolation of juvenile hormone esterase and its partial cDNA clone from the beetle, Tenebrio molitorB A Thomas, A C Hinton, H Moskowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2013
False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphomaGary A Ulaner, Joshua Lilienstein, Mithat Gönen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 25, 2009
High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphomaDaniel O Persky, Craig H Moskowitz, Alexander Filatov, et al.
British Journal of Haematology|February 12, 2004
Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's diseaseCraig H Moskowitz, Tarun Kewalramani, Stephen D Nimer, et al.
Leukemia Research|May 28, 2013
Tumor associated macrophages in relapsed and refractory Hodgkin lymphomaCarla Casulo, Maria Arcila, Olga L Bohn, et al.
Pageof 28

Showing results (131-140 of 280) with videos related to

Sort By:
Pageof 28
JAMA Dermatology|November 22, 2013
Disseminated mantle-cell lymphoma presenting as a petechial maculopapular eruptionSarah I Jawed, Travis J Hollmann, Craig H Moskowitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2003
Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphomaA D Zelenetz, P Hamlin, T Kewalramani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphomaKaryn A Goodman, Elyn Riedel, Victoria Serrano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2022
Prognostic Value of <sup>18</sup>F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy RegimenLaure Michaud, Kurt Bantilan, Audrey Mauguen, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1994
Synthesis of an antileishmanial alkaloid isolated from Galipea longiflora and of related compoundsM H Munos, J Mayrargue, A Fournet, et al.
Insect Biochemistry and Molecular Biology|June 14, 2000
Isolation of juvenile hormone esterase and its partial cDNA clone from the beetle, Tenebrio molitorB A Thomas, A C Hinton, H Moskowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2013
False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphomaGary A Ulaner, Joshua Lilienstein, Mithat Gönen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 25, 2009
High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphomaDaniel O Persky, Craig H Moskowitz, Alexander Filatov, et al.
British Journal of Haematology|February 12, 2004
Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's diseaseCraig H Moskowitz, Tarun Kewalramani, Stephen D Nimer, et al.
Leukemia Research|May 28, 2013
Tumor associated macrophages in relapsed and refractory Hodgkin lymphomaCarla Casulo, Maria Arcila, Olga L Bohn, et al.
Pageof 28